Coaptite – Enrollment Closed
A post –approval study to assess the long term safety and effectiveness Coaptite for the treatment of female urinary incontinence.
Inclusion Criteria:
- Has female urinary stress incontinence that is due to intrinsic sphincter deficiency
- Has a baseline pas weight of >50 grams
- Age > 18 years
- Has a viable mucosal lining at likely site of injection (bladder neck)